Stage
DivestitureTotal Raised
$265MInvestors Count
3Deal Terms
2Portfolio Exits
1SYNLAB Funding, SYNLAB Valuation & SYNLAB Revenue
5 Fundings
SYNLAB's latest funding round was a IPO for on April 28, 2021.
SYNLAB's valuation in April 2017 was $1,325M.
SYNLAB's latest post-money valuation is from April 2017.
Sign up for a free trial to see SYNLAB's valuations in June 2015 and more.
SYNLAB's 2016 revenue was $1.71B. SYNLAB's most recent revenue is from 2016.
Sign up for a free trial to see revenue data from 2016 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
4/28/2021 | IPO | 1 | ||||
4/12/2017 | Corporate Minority - II | $1,325M | ||||
12/16/2016 | Corporate Minority | $1.71B FY 2016 | ||||
6/26/2015 | Acq - Fin | |||||
9/2/2009 | Private Equity |
Date | 4/28/2021 | 4/12/2017 | 12/16/2016 | 6/26/2015 | 9/2/2009 |
|---|---|---|---|---|---|
Round | IPO | Corporate Minority - II | Corporate Minority | Acq - Fin | Private Equity |
Amount | |||||
Investors | |||||
Valuation | $1,325M | ||||
Revenue | $1.71B FY 2016 | ||||
Sources | 1 |
SYNLAB Deal Terms
2 Deal Terms
SYNLAB's deal structure is available for 2 funding rounds, including their Corporate Minority - II from April 12, 2017.
Round | Corporate Minority - II | Acq - Fin |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Corporate Minority - II | |||||||||||||||
Acq - Fin |
SYNLAB Investors
3 Investors
SYNLAB has 3 investors. Novo Holdings invested in SYNLAB's Corporate Minority - II funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
12/16/2016 | 4/12/2017 | 2 Corporate Minority, Corporate Minority - II (2017) | Holding Company | Denmark | ||
Private Equity | United Kingdom | |||||
Private Equity | United Kingdom |
First funding | 12/16/2016 | ||
|---|---|---|---|
Last Funding | 4/12/2017 | ||
Investor | |||
Rounds | 2 Corporate Minority, Corporate Minority - II (2017) | ||
Board Seats | |||
Type | Holding Company | Private Equity | Private Equity |
Location | Denmark | United Kingdom | United Kingdom |
SYNLAB Acquisitions
7 Acquisitions
SYNLAB acquired 7 companies. Their latest acquisition was Sistemas Genomicos on January 07, 2022.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
1/7/2022 | Acquired | 1 | ||||
8/2/2021 | ||||||
8/2/2021 | ||||||
7/26/2021 | ||||||
9/8/2018 |
Date | 1/7/2022 | 8/2/2021 | 8/2/2021 | 7/26/2021 | 9/8/2018 |
|---|---|---|---|---|---|
Investment Stage | |||||
Companies | |||||
Valuation | |||||
Total Funding | |||||
Note | Acquired | ||||
Sources | 1 |
SYNLAB Portfolio Exits
1 Portfolio Exit
SYNLAB has 1 portfolio exit. Their latest portfolio exit was SGS Analytics on November 10, 2020.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
11/10/2020 | Divestiture | 9 |
Date | 11/10/2020 |
|---|---|
Exit | Divestiture |
Companies | |
Valuation | |
Acquirer | |
Sources | 9 |
You May Also Like
Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. The company utilizes AI and biomarkers to improve patient outcomes. It was founded in 2020 and is based in Cambridge, England.
Laboratory Corporation of America Holdings (NYSE: LH), dba LabCorp, provides medical laboratory tests and services through a national network of primary clinical laboratories. Its clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies.
Unilabs is a European supplier of laboratory and radiology services to private and public health care units, government bodies, insurance companies, the general public and to parts of the pharmaceutical industry. It covers the full spectrum of diagnostics across laboratory, imaging and pathology services at scale and operates in twelve countries in Europe. It is based in Geneva, Switzerland.On December 3rd, 2021, Unilabs was acquired by AP Moller Holding. The terms of the transaction were not disclosed.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.